Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,230.00    -160.00 (-2.97%)
Bid:
5,195.00
Ask:
5,205.00
Spread: 10.00 (0.192%)
Market Cap: £3.80b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Form 8.3 - Renishaw Plc

5 May 2021 12:33

RNS Number : 6562X
Baillie Gifford & Co.
05 May 2021
Β 

FORMΒ 8.3

Β 

PUBLICΒ OPENINGΒ POSITIONΒ DISCLOSURE/DEALINGΒ DISCLOSUREΒ BY

AΒ PERSONΒ WITHΒ INTERESTSΒ INΒ RELEVANTΒ SECURITIESΒ REPRESENTINGΒ 1%Β OR MORE

RuleΒ 8.3Β ofΒ theΒ TakeoverΒ CodeΒ (theΒ "Code")

Β 

1. KEYΒ INFORMATION

Β 

(a) Full name of discloser:

Baillie Gifford & Co

(b) Owner or controller of interests and short

positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose

relevant securities this form relates:

Use a separate form for each offeror/offeree

Renishaw Plc

(d) If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

04 May 2021

(f) In addition to the company in 1(c) above, is the

discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

Β 

2. POSITIONSΒ OFΒ THEΒ PERSONΒ MAKINGΒ THEΒ DISCLOSURE

Β 

IfΒ thereΒ areΒ positionsΒ orΒ rightsΒ toΒ subscribeΒ toΒ discloseΒ inΒ moreΒ thanΒ oneΒ classΒ ofΒ relevant securitiesΒ ofΒ theΒ offerorΒ orΒ offereeΒ namedΒ in 1(c),Β copyΒ tableΒ 2(a)Β orΒ (b)Β (as appropriate)Β for eachΒ additionalΒ classΒ of relevantΒ security.

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ inΒ theΒ relevantΒ securitiesΒ ofΒ theΒ offerorΒ orΒ offeree toΒ whichΒ theΒ disclosureΒ relatesΒ followingΒ theΒ dealingΒ (ifΒ any)

Β 

Class of relevant security:

20p Ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned

and/or controlled:

4,989,516

6.85

(2) Cash-settled derivatives:

(3) Stock-settled derivatives

(including options) and agreements to purchase/sell:

Β 

TOTAL:

4,989,516

6.85

Β 

AllΒ interestsΒ andΒ allΒ shortΒ positionsΒ shouldΒ be disclosed.

Β 

Details Β of Β any Β open Β stock-settled Β derivative Β positions Β (including Β traded Β options), Β or agreementsΒ toΒ purchaseΒ orΒ sellΒ relevantΒ securities,Β shouldΒ beΒ givenΒ onΒ aΒ Supplemental FormΒ 8Β (OpenΒ Positions).

(b) RightsΒ toΒ subscribeΒ forΒ newΒ securitiesΒ (includingΒ directors'Β andΒ otherΒ employee options)

Β 

Class of relevant security in relation to

which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

3. Β DEALINGSΒ (IFΒ ANY)Β BYΒ THEΒ PERSONΒ MAKINGΒ THEΒ DISCLOSURE

Β 

WhereΒ thereΒ have beenΒ dealingsΒ in moreΒ than oneΒ classΒ of relevantΒ securitiesΒ of theΒ offerorΒ or offeree named inΒ 1(c), copyΒ table 3(a), (b), (c)Β orΒ (d)Β (asΒ appropriate)Β forΒ each additionalΒ class ofΒ relevantΒ securityΒ dealtΒ in.

Β 

TheΒ currencyΒ ofΒ allΒ pricesΒ andΒ otherΒ monetaryΒ amountsΒ shouldΒ beΒ stated.

Β 

(a) Β PurchasesΒ andΒ sales

Β 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

20p Ordinary

Purchase

555

61.841

Β 

(b) Cash-settledΒ derivativeΒ transactions

Β 

Class of

relevant security

Product

description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of

reference securities

Price per

unit

Β 

(c) Stock-settledΒ derivativeΒ transactionsΒ (includingΒ options)

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Class

of relevant security

Product

description e.g. call option

Writing,

purchasing, selling, varying etc.

Number

of securities to which option relates

Exercise

price per unit

Type

e.g. American, European etc.

Expiry

date

Option

money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of

relevant security

Product

description

e.g. call option

Exercising/

exercised against

Number of

securities

Exercise price

per unit

(d) OtherΒ dealingsΒ (includingΒ subscribingΒ forΒ newΒ securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

4. OTHERΒ INFORMATION

Β 

(a) IndemnityΒ andΒ otherΒ dealingΒ arrangements

Β 

DetailsΒ ofΒ anyΒ indemnityΒ orΒ optionΒ arrangement,Β orΒ anyΒ agreementΒ orΒ understanding, formalΒ orΒ informal,Β relatingΒ toΒ relevantΒ securitiesΒ whichΒ mayΒ beΒ anΒ inducementΒ toΒ deal orΒ refrainΒ fromΒ dealingΒ enteredΒ intoΒ byΒ theΒ personΒ makingΒ theΒ disclosureΒ andΒ anyΒ party toΒ theΒ offerΒ orΒ anyΒ personΒ actingΒ inΒ concertΒ withΒ aΒ partyΒ toΒ theΒ offer:

IrrevocableΒ commitmentsΒ andΒ lettersΒ of intentΒ shouldΒ notΒ be included.Β IfΒ thereΒ areΒ noΒ such agreements,Β arrangementsΒ orΒ understandings,Β stateΒ "none"

Β 

None

Β 

Β 

Β 

(b) Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

DetailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understanding,Β formalΒ orΒ informal,Β between theΒ personΒ makingΒ theΒ disclosureΒ andΒ anyΒ otherΒ personΒ relatingΒ to:

(i)Β theΒ votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option;Β or

(ii)Β theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ orΒ disposalΒ ofΒ anyΒ relevantΒ securitiesΒ toΒ which anyΒ derivativeΒ isΒ referenced:

IfΒ thereΒ areΒ noΒ suchΒ agreements,Β arrangementsΒ orΒ understandings,Β stateΒ "none"

Β 

Β 

None

Β 

Β 

(c) Attachments

Β 

IsΒ aΒ SupplementalΒ FormΒ 8 (OpenΒ Positions)Β attached? NO

Β 

Β 

Β 

Date of disclosure:

05.05.2021

Contact name:

Alan Gilliland-Patterson

Telephone number:

0131 275 3779

Β 

PublicΒ disclosuresΒ underΒ RuleΒ 8Β ofΒ theΒ CodeΒ mustΒ beΒ madeΒ toΒ aΒ RegulatoryΒ Information

Service.

Β 

TheΒ Panel'sΒ MarketΒ SurveillanceΒ UnitΒ isΒ availableΒ forΒ consultationΒ inΒ relationΒ toΒ theΒ Code's disclosureΒ requirementsΒ on +44Β (0)20Β 7638Β 0129.

Β 

TheΒ CodeΒ canΒ be viewedΒ onΒ the Panel'sΒ websiteΒ atΒ Β www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETSSFFFIEFSEDI
Date   Source Headline
22nd Sep 20203:11 pmRNSReplacement Director/PDMR Shareholding
22nd Sep 20202:19 pmRNSDirector/PDMR Shareholding
8th Sep 20204:35 pmRNSDirector/PDMR Shareholding
1st Sep 20207:00 amRNSAnnual Financial Report
27th Aug 20207:00 amRNSDirector/PDMR Shareholding
17th Aug 20203:15 pmRNSDirector/PDMR Shareholding
13th Aug 20207:00 amRNSFinal Results
6th Aug 202010:00 amRNSNotice of Results
17th Jul 20208:06 amRNSTrading Statement
26th Jun 20201:08 pmRNSDirector/PDMR Shareholding
24th Jun 20203:35 pmRNSDirector/PDMR Shareholding
22nd Jun 20204:17 pmRNSDirector/PDMR Shareholding
10th Jun 20202:00 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNS2020 Final Dividend
12th May 20207:00 amRNSTrading Statement
4th May 202012:00 pmRNSDisclosure of Rights Attached to Equity Shares
2nd Apr 20204:30 pmRNSStatement re 2019 AGM resolution votes
25th Mar 20204:28 pmRNSStatement re Interim dividend
6th Mar 20209:36 amRNSDirector/PDMR Shareholding
27th Feb 20204:47 pmRNSStatement re Interim dividend
30th Jan 20207:00 amRNSHalf-year Report
29th Jan 20205:45 pmRNSChange in Director's Responsibilities
20th Jan 202012:00 pmRNSNotice of Half-year Results
17th Jan 20209:47 amRNSHolding(s) in Company
24th Oct 20193:37 pmRNSResult of AGM
15th Oct 20197:00 amRNSTrading Statement
30th Aug 20193:00 pmRNSPurchase of Shares by Profit Share Trust
21st Aug 20197:00 amRNSAnnual Financial Report
1st Aug 20197:00 amRNSFinal Results
16th Jul 20193:00 pmRNSNotice of Results
25th Jun 20197:00 amRNSDirectorate Change
14th May 201910:00 amRNSDirector Declaration
14th May 20197:00 amRNSTrading Statement
27th Mar 201911:36 amRNSDirector/PDMR Shareholding
22nd Mar 20199:48 amRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSTrading Statement
12th Mar 20194:00 pmRNSNotice of Investor Day
31st Jan 20197:00 amRNSHalf-year Report
15th Jan 20193:00 pmRNSNotice of Half-year Results
19th Dec 201810:07 amRNSDirector/PDMR Shareholding
29th Oct 20189:56 amRNSDirector/PDMR Shareholding
23rd Oct 201810:02 amRNSDirector/PDMR Shareholding
22nd Oct 201810:43 amRNSDirector/PDMR Shareholding
18th Oct 20184:02 pmRNSResult of AGM
18th Oct 20187:00 amRNSTrading Statement
23rd Aug 20182:00 pmRNSPurchase of Shares by Profit Share Trust
21st Aug 20187:00 amRNSAnnual Financial Report
3rd Aug 201812:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20183:00 pmRNSDirector Declaration
26th Jul 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.